Do DAN-GER-SHOCK eligible patients benefit from VA-ECMO treatment in infarct-related cardiogenic shock ? Results of an individual patient data meta-analysis.

Back

ESC Premium Access

Do DAN-GER-SHOCK eligible patients benefit from VA-ECMO treatment in infarct-related cardiogenic shock ? Results of an individual patient data meta-analysis.

Session: Acute heart failure and cardiogenic shock in acute coronary syndromes

Topic: Shock

Speaker: Professor U. Zeymer (Ludwigshafen, DE)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Professor Uwe Zeymer

Klinikum Ludwigshafen, Ludwigshafen (Germany)

18 presentations

3 followers

6 more presentations in this session

VA-ECMO-related complications seem not causally related to mortality in patients with acute myocardial infarction complicated by cardiogenic shock

Speaker: Doctor T. Thevathasan (Berlin, DE)

STEMI SHOCK outcomes with SCAI classification

Speaker: Professor J. French (Sydney, AU)

Association of culprit lesions with in-hospital mortality in patients with acute coronary syndrome complicated by cardiogenic Shock

Speaker: Doctor S. Matsushita (Kurashiki, JP)

Impact of inhaled nitric oxide therapy in patients with cardiogenic shock treated with veno-arterial extracorporeal membrane oxygenation combined with Impella

Speaker: Doctor M. Ueno (Osaka, JP)

Impact of late reperfusion therapy in patients with inferior ST-segment elevation myocardial infarction and right ventricular dysfunction: one size never fits all

Speaker: Doctor A. Hernandez Pineda (Barcelona, ES)

Access the full session

Acute heart failure and cardiogenic shock in acute coronary syndromes

Speakers: Professor U. Zeymer, Doctor T. Thevathasan, Professor J. French, Doctor S. Matsushita, Doctor M. Ueno...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources